A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion
Public ClinicalTrials.gov record NCT01277302. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter Randomized Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This was a Phase IV multicenter, randomized, open-label study, with masking of the vision examiner, of the efficacy and safety of intravitreal ranibizumab 0.5 mg in subjects with macular edema following Branch Retinal Vein Occlusion (BRVO) or Central Retinal Vein Occlusion (CRVO).
Study identification
- NCT ID
- NCT01277302
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 202 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2011
- Primary completion
- Sep 30, 2012
- Completion
- Sep 30, 2012
- Last update posted
- Apr 22, 2014
2011 – 2012
United States locations
- U.S. sites
- 42
- U.S. states
- 20
- U.S. cities
- 41
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85020 | — |
| Not listed | Tucson | Arizona | 85704 | — |
| Not listed | Beverly Hills | California | 90211 | — |
| Not listed | Chico | California | 95973 | — |
| Not listed | Mountain View | California | 94040 | — |
| Not listed | Oakland | California | 94609 | — |
| Not listed | San Francisco | California | 94107 | — |
| Not listed | Santa Ana | California | 92705 | — |
| Not listed | Santa Barbara | California | 93103 | — |
| Not listed | Torrance | California | 90503 | — |
| Not listed | Colorado Springs | Colorado | 80909 | — |
| Not listed | Golden | Colorado | 80401 | — |
| Not listed | New London | Connecticut | 06320 | — |
| Not listed | Altamonte Springs | Florida | 32701 | — |
| Not listed | Boynton Beach | Florida | 33426 | — |
| Not listed | Lakeland | Florida | 33805 | — |
| Not listed | Augusta | Georgia | 30909 | — |
| Not listed | Chicago | Illinois | 60637 | — |
| Not listed | Baltimore | Maryland | 21287 | — |
| Not listed | Hagerstown | Maryland | 21740 | — |
| Not listed | Boston | Massachusetts | 02114 | — |
| Not listed | Worcester | Massachusetts | 01605 | — |
| Not listed | Jackson | Michigan | 49201 | — |
| Not listed | Edina | Minnesota | 55435 | — |
| Not listed | Las Vegas | Nevada | 89144 | — |
| Not listed | Northfield | New Jersey | 08225 | — |
| Not listed | Teaneck | New Jersey | 07666 | — |
| Not listed | Rochester | New York | 14620 | — |
| Not listed | Charlotte | North Carolina | 28210 | — |
| Not listed | Camp Hill | Pennsylvania | 17011 | — |
| Not listed | Philadelphia | Pennsylvania | 19107 | — |
| Not listed | Pittsburgh | Pennsylvania | 15212 | — |
| Not listed | Pittsburgh | Pennsylvania | 15213 | — |
| Not listed | Ladson | South Carolina | 29456 | — |
| Not listed | West Columbia | South Carolina | 29169 | — |
| Not listed | Rapid City | South Dakota | 57701 | — |
| Not listed | Nashville | Tennessee | 37203 | — |
| Not listed | Abilene | Texas | 79606 | — |
| Not listed | Austin | Texas | 78705 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | San Antonio | Texas | 78240 | — |
| Not listed | The Woodlands | Texas | 77384 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01277302, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 22, 2014 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01277302 live on ClinicalTrials.gov.